[Stereotactic body radiotherapy (SBRT) -- an overview under special consideration of SBRT and LITT in the therapy of liver metastases].
Stereotactic body radiotherapy (SBRT) is a high dose radiotherapy, the radiation dose is applicated one-time or in a few fractions exactly to the tumor or metastases under maximal separation from the normal tissue. Because of this a major expenditure of medical and technical efforts are necessary, a detailed description of the proceedings is following in the methodic part of this article. Indications of SBRT are especially medical irresectable lung tumors of early stages, primary liver/biliary tumors and pulmonary or liver metastases if there is an oncological benefit for the patients. The side effects are moderate, the local tumor control rate is between 78 to 100 %. Depending on the primary tumor the overall survival is prolonged statistically significant. In the Klinikum Krefeld indications of SBRT vs chemotherapy, LITT or resection are discussed by an interdisciplinary conference of gastroenterologists/oncologists, radiologists, radiooncologists and surgeons. An example of LITT will be shown also.
Ernst
I
I
Klinik für Strahlentherapie und Radiologische Onkologie, Klinikum Krefeld, Akademisches Lehrkrankenhaus der Universität Düsseldorf, Krefeld, Deutschland. ernst_stra@klinikum-krefeld.de
Lücking
P S
PS
Eickmeyer
F
F
Beckers
E
E
Roth
A
A
Schneid
S
S
Schwarzmaier
H-J
HJ
Fiedler
V U
VU
Schulz
U
U